Peer Review History
| Original SubmissionSeptember 2, 2019 |
|---|
|
PONE-D-19-24706 The influence of hip muscle strength on gait in individuals with a unilateral transfemoral amputation – a prospective cohort study PLOS ONE Dear Mr. Heitzmann, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We would appreciate receiving your revised manuscript by Jan 18 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Yih-Kuen Jan, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service. Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services. If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free. Upon resubmission, please provide the following:
3. Thank you for stating the following in the Competing Interests section: 'The authors have declared that no competing interests exist.' We note that one or more of the authors are employed by a commercial company: 2Guenther Bionics GmbH.
Please also include the following statement within your amended Funding Statement. “The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.” If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement. 2. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc. Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests) . If this adherence statement is not accurate and there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf. Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests 4. Please include a copy of Table 3 which you refer to in your text on page 20. Additional Editor Comments (if provided): [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The manuscript reports results from a study examining the changes in gait kinematics and joint moments that occur in a cohort of participants with transfemoral amputations (pTFA), and their relationship to isometric joint moments. To do this, the authors use an isometric force measurement rig in conjunction with marker based clinical gait analysis to compare maximum isometric joint moments (MIM) with joint moments and kinematics measured during walking. The experiment design appears solid (although clarifications are needed), and the results show consistent reductions in maximum isometric moment for hip abduction, adduction, and flexion, correlations between isometric and gait joint moments, and a moderate correlation between isometric hip abduction moment and trunk movement. As the authors point out in the discussion, many of the findings agree with previous studies looking at isometric moment generation or gait kinetics/kinematics in pTFA, although here the authors are also able to examine relationships between the two metrics. Overall the manuscript is well written. There are a variety of minor issues that require correction or clarification in the manuscript but most are relatively easily addressed. Clearly this is a rich dataset with a wide number of measures obtained during testing, particularly during gait. It looks like table 2 lists all of the measures examined but it would be helpful for the reader if they were stated more explicitly in the methods, possibly as a list of the planned study measures before they are detailed in the main text. The nonparametric statistical testing for group differences is appropriate, however, it is not clear whether corrections for multiple comparisons were applied to help control for false positive results given the number of tests. The Discussion is quite long, which is not necessarily a problem, although there are a number of associations made between pTFA and other populations (e.g. hip luxation, cereberal palsy, Legg Calve’ Perthes, etc.), for which the rationale is not always clear given the inherent differences between such groups. Page 6 (lines 116-121), The point the authors are trying to make with Sherk et al. is not very clear. Page 12 (line 249), please clarify why adjustments for the characteristics of the prosthesis were not made when calculating joint kinetics. This would seem likely to have an impact on the measures. Page 13 (line 266), references Figure 1C which is not present in Figure 1. (line 271), notes that marker trajectories were measured during isometric testing but their use is not clarified later on. (line 287) indicates that the “best trial” was used. Please clarify how this was defined. Figure 3, The content of the figure is not clear and the caption does not explain all elements of what is being presented. For example, the titles suggest an x vs. y comparison of the title variables in the plots but the independent variable appears to be gait cycle (although abbreviations are not defined). Shading and dotted lines are not defined in the caption. Please also doublecheck the phrasing ‘none continual scalar’. Page 19, reports the spearman correlations between various metrics in TFA but it is unclear how the levels of correlation relate to controls, which are not presented. Page 22 (lines 425-427), if the participants maximum isometric joint moment was being measured in the study (which generally speaking should be the largest moment that can be generated), it is unclear how/why moments generated during gait would necessarily exceed it. Figure S1 caption, please indicate what the ranges correspond to. Other minor comments and suggested edits (insertions/deletions in brackets), Please verify that past tense grammar is consistent throughout the manuscript Page 4 (line 84), “… might [be] helpful…” Page 6 (line 127), “…Additional[ly]…” (line 132), “…compromise[d]…” (line 135), “…who [was] utilizing…” Page 7 (line 156), “…walking [is] coronal plane…” (line 159), “…and [] irregularities…” (line 161), “…TFA [out] of a ….” (line 164), “…this may [also] be related to…” Page 8 (line 179), “…role of [muscle] strength…” Page 9 (line 190), delete “of the department” Page 16 (line 325-326), “…vie [of] each side…present[ed]…”, “conjunct” spelling? Page 21 (line 390), “…patter[n]…” Page 22 (line 426), “…if this [] working…” Page 23 (line 445), “…socket do[es] not…” Reviewer #2: The goal of the manuscript is to examine the influence of hip muscle strength on walking biomechanics for persons with transfemoral amputation. The authors hypothesize that: “people with [transfemoral amputation] TFA will show lower isometric moments on the involved side than those in reference a group (REF); we expect correlations between maximum isometric joint moments and gait kinematics of the hip, pelvis, and trunk; and, further, we expect correlations between maximum hip joint moments in gait with those tested isometrically.” The authors prove their hypothesis and show that persons with transfemoral amputation have reduced hip muscle strength as compared to healthy individuals, but do not attempt to decouple the effects of reduced hip muscle strength and differences in leg length due to the transfemoral prosthesis for the gait deviations observed. It is recommended that the authors perform additional analyses to examine the role of the transfemoral prosthesis on the gait deviations observed rather than ignoring this confounding factor. Major: In the discussion and conclusion, the authors link decreased hip ab/adduction moment to changes in hip and trunk kinematics. While this may be a factor, the reviewer does not believe it is the cause of the kinematic changes. Most prosthetists make create a transfemoral prosthetic system that causes the prosthetic limb to be longer than the sounds limb so that during walking the user compresses the prosthetic foot during stance. This can lead poor hip alignment during standing and during the stance phase of walking if the user does not meaningfully progress onto the prosthesis during this time. Additionally, this longer prosthetic leg can lead to hip hiking during swing. Did the authors examine the trunk obliquity and hip alignment during a static trial? Additionally, the authors could examine the effective leg-length throughout walking by examining a vector from the hip joint center to the center-of-pressure under the foot. Such a vector should be compared to the sound limb to see if the effective limb length is the same. This would allow the authors to make a more concrete statement about how the subjects interact with the prosthesis and if the observed hip and trunk kinematic changes are due to leg length changes or due to weak hip musculature. The introduction and discussion are clunky. The authors often introduce a source and then explain what the study concluded (or the inverse). For example: “Pröbsting et al. gathered studies on changes in the musculoskeletal system as a result of lower-limb amputation [1]. They categorized these musculoskeletal changes as follows: low back pain, osteoarthritis, reduced bone density, and muscle atrophy.” This type of referencing occurs 15+ times throughout the introduction and reduces the readability of the article. It is encouraged for the authors to concisely revise the introduction and discussion. An example for the previous quote would be: “Noted musculoskeletal comorbidities following lower-limb amputation are: low back pain, osteoarthritis, reduced bone density, and muscle atrophy [1].” Make sure to check the grammar and punctuation throughout the manuscript. The reviewer has listed several grammar and punctuation items that need to be addressed in the introduction but did not do so for the entire manuscript. Minor: This is not a prospective study as there was not an extended period of time that the subjects were examined over. Please remove such wording from the title and the manuscript. Make sure to have continuous past tense throughout the manuscript Introduction: Line 91: need a comma instead of and between “integrity” and “perception” Line 102: “this” to “muscles strength” as in the previous sentence you refer to muscle atrophy, amputation and strength Line 109: “Medial” instead of ventral? The reviewer does not know what the ventral side of the thigh is. Line 114: add “muscles” to the end of the sentence. Line 127: “Addition” to “Additionally,” Line 132: “compromise” to “compromised” Line 138: “Additionally” Line 156-157: “A well-known example of how strength deficits impact walking are probably coronal plane gait deviations of the trunk, as described by Trendelenburg [23].” Is not a definitive sentence. Line 178-179: Remove: “We are confident that by using this approach we will gain better insight into the role of strength in people with TFA and their compensation mechanisms in gait.” Methods: How much does the K2 subject skew the results? Should he/she be eliminated from subsequent analyses? This subject, as reported, does not spend as much time on the prosthesis as the other subjects and is the only subject collected that was classified as K2. Lines 190-191: remove “of the department” Line 217: Define the acronym MRC Lines 221-222: Were these sockets different than their daily use sockets? If they were, how much do you think this affects the gait outcomes of the manuscript? Line 225: Define the acronym LASAR Lines 249-250: How does not adjusting for the prosthetic inertial parameters affect the joint kinetics? And how does this affect the comparisons the authors make between able-bodied and persons with transfemoral amputation? Line 266: a comma is needed Line 288-291: The reviewer does not understand the how this portion is relevant. What was being correlated to provide a high correlation? Line 289: put (ICC) after interclass correlation coefficient Line 294: Please define PTFA acronym. Results: Why compare peak-to-peak maximum isometric moments? This would seem to penalize persons with amputation or hip musculature weakness more. Additionally, this does not provide an accurate characterization of the musculature which is only active in one direction. It is strongly recommended to separate out different motions as is reported in Lines 352 to 355 of the discussion and to not use the peak-to-peak range. Line 313: include “during walking” to the end of the topic sentence. Table 2: It is encouraged to not statistically compare gait parameters between the persons with amputation and healthy individuals as they had a significantly different gait velocity. It has been shown that differences in gait velocity cause differences in lower limb kinematics and kinetics (see Zelik and Kuo 2010). Figure 3: Please update the healthy line color as the reviewer cannot see the mean line. Figure 3 caption: please include the mean walking velocities for the persons with amputation and healthy individuals. Line 322: this was not a significant finding. why report without significance? Can the authors include a table with the variables correlated, the correlation values and the significance of the correlation values? Discussion: Line 350: “Individuals” Lines 355-358: The reviewer does not see the relevance in reporting the ranges in the MIM. See comment above. Line 363: “und” to “and” Lines 368 to 438: Paragraph may want to be broken up to improve readability. Also, the authors refer to many different clinical populations (ex: children with Legg Calve´ Perthes disease, persons with cerebral palsy). This provides un-useful information as many clinical populations may suffer from different co-morbidities which makes the population unique and less relatable to each other. Lines 411-420: Seems to be reiteration of the results with no real discussion going on. Additionally, are all the correlation values significant that are cited? Line 425: “In theory one could imagine these peak to peak values as a working range and if this this working range will be surpassed by moments occurring during gait this may induce gait deviations or even make it impossible to walk.” These peak to peak ranges are exceeded during human running (see Riddick et al. 2018) for healthy individuals. The reviewer does not feel that this hypothesis can be supported as human locomotion exceeds these thresholds. It is recommended to temper the language. The review thinks that the Author’s statement of: “Strength deficits may force individuals with TFA into compensation mechanisms, which should be distinguished from socket or prosthesis-induced gait alterations. External factors inducing the significant strength deficits in people with TFA cannot be fully identified in this study.” is the crux of the article and should be stated earlier in the discussion than line 462. Line 466-467: “The hip abductors are not directly weakened by the transfemoral amputation itself.” is a misleading statement. The hip abduction muscles may not loose muscle mass during the amputation BUT the thigh muscles are “tacked down” onto the femur or may not even be attached. In the former case, the muscle loses the moment arm at which it acts, effectively making it weaker to perform the necessary task. Line 470-481: Why do the authors interpret non-significant results as significant results? Conclusion: The authors state that this information may be helpful for rehabilitation. The authors should discuss such implication in the discussion. Reviewer #3: This manuscript investigates potential correlations of strength gait deviations, as well as compared a cohort of people with transfemoral amputation to people without amputation. The topic of this article is interesting because if we could see a gait deviation and then address it with rehabilitation (e.g., strength or balance), it would help people with amputation walk with less deviations. I have a series of comments below that reference major and minor concerns, and I have highlighted some of them with line numbers but did not highlight every instance that is repeated throughout the manuscript. General questions: Is maximal strength important with over ground preferred walking speed, or is it more important to show how much of their overall capacity they need to use to walk compared with non-amputees? Is there a greater reserve strength for non-amputees? Maybe a deviation is chosen to save available muscle fibers and reserve capacity to respond to perturbations or minimize energy expenditure. Major Comments Abstract: Line 51: Is this a prospective study? A prospective study identifies a population and then follows them and tries to make predictions about what will happen, whereas here you are trying to make correlations between gait deviations and strength deficits. Lines 51-53: Aside from the prospective study comment, I like this statement because it is clear about what you did in this study. Introduction: Line 95: This is something done many times throughout the manuscript, and may just be a personal preference on my part, but other authors should be cited while their findings are prominent. “Probsting…” sentence adds nothing. Then line 104, “Ostchega et al….” did not prove a relationship, the results or findings of a study show something, the authors just write it up. Also, there are very few proven relationships, there is more evidence for some things than others, but one study (and multiple studies) does not prove a relationship. Line 102: Unless you plan on talking about other forms of mobility, such as transfers, just say “this relates to walking.” Throughout the introduction there could be more standalone paragraphs, and rather than listing findings from study after study, the information could be synthesized or summarized. This relates to my comment above about authors not showing anything, but the overall data collected from many studies. Lines 173 and 174: There should not be methods in the introduction. Lines 182-183: Should hypothesized directionality of correlations, not just state there will be correlations. Methods: Line 213-215: I am not sure if participant 8 should be included in the data analysis, especially since he is a K2 ambulator and then he walked without crutches during his motion analysis. Walking without crutches is not his normal or preferred, and therefore the gait speed and mechanics are not preferred, whereas the participants were using preferred mechanics. Lines 267-268: Did you standardize the amount of test trials for participants to try the OpTIMo? Lines 284: General questions about OpTIMo, how widespread is this device clinically or in research? Is it a research-only device? How does it compare to typical clinical force dynamometry measures with patients laying down? Line 287: What makes a trial the best? Line 295: Why not look at the sound side too? Could be interesting when comparing to affected side and unaffected participants. Statistics look right. Results: Line 310-311: All the differences were significant except for the step length. Figure 3: Should label x and y axes rather than leave that to the title. Also, I do not know what FS, FO, oFS, and oFO are, I assume they are foot strike and foot off, but do not know. Lines 342-345: What does negative and positive correlations mean in your results? Discussion: General comment: Should not repeat results, especially with p-values, in the discussion section, they should be in the results section alone. Line 375: Remove distinguished, that is your spin and unnecessary. Line 382: The results from Cappozzo agree with your results, do not confirm your results, and if anything, your results confirm their finding. Lines 409-421: Listing many results in the discussion section, could be synthesized with the literature better. Minor Comments Abstract: Line 47: Awkward wording “on the person concerned” Line 59: should be “Kinematics” not “Kinematic” Line 59: Could say determined, not derived, unless you derived equations. Line 72: Could say “were identified, i.e. significantly lower speed,…” Introduction: Line 91: Could say “body integrity, perception…” Line 98: “clear atrophy” does not make sense, atrophy alone works Line 98: I recommend saying amputated or affected side, rather than ipsilateral side. I understand ipsilateral but I am not sure every reader will, it is more clear to say something like amputated, affected or involved. Line 102: “particularly” does not add anything, like most adverbs Line 126: What do you mean by “redundant”? Line 127: Could say “Additionally, the…” Line 128: What do you mean by “finite coupling”? Line 130: Could say “Gholizadeh et al. underline the problems in…” Line 138: Could say “Additionally, new…” Line 164: Lower case i in ischial Methods: Line 193: clinical gait analysis can be replaced with CGA because the acronym is already listed in the beginning Line 225: Is the L.A.S.A.R. posture device widely known? I am not sure if it should be explained more or you could stop the sentence with “recommendations.” Line 240: What was the collection rate for the force plates? Results: Line 315: “in the patients” is awkward wording Lines 320-321: “For CGA…the patient group.” is not a clear sentence, could be written better. Line 325: Why is this schematic “exemplary”? In table 2, Kg should be kg, and it should be N m and not Nm because they are 2 separate words. Line 339: Should say “with TFA hip MIM of…” and not “with TFA Hip MIMof…” Discussion: Line 390: pattern, not patter Line 445: Say For example, no E.g. to lead a sentence Line 445: does rather than do Line 449-452: Not a clear sentence. Line 452: stabilize rather than stabile Line 501: address rather than tackle deficits, tackle is in American football or Rugby rather deficits of our patients/clients ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-19-24706R1 The influence of hip muscle strength on gait in individuals with a unilateral transfemoral amputation PLOS ONE Dear Dr. Heitzmann, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 17 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Yih-Kuen Jan, PhD Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: (No Response) Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The revised manuscript has been extensively rewritten in response to the reviewers’ comments. The literature in the introduction is now presented in a more synthesized form, the statistical analyses have been revised to account for multiple comparisons, and the discussion has largely been re-written to better relate the results to the literature and discuss the impact of potential confounds. In doing so, the clarity of the manuscript has been improved. A few minor issues remain, which should be addressed prior to publication. The methods indicate that Spearman’s rank correlation was used, but in some places the results refer to “linear correlations” (e.g., Line 505 and S2_Figure). If the references to a linear correlation are correct, please include in the methods. In not, I would suggest removing the reference to ‘linear’ and the line fits in S2_Figure, since the spearman rank correlation characterizes the monotonic relationship between two variables, which is less restrictive than assuming a linear relationship. Lines 278-280, suggest revising to read, “The level of significance for correlations was corrected to p < .0036 to account for testing across the coronal and sagittal plane CGA and MIM parameters.” Lines 293 & 297, I believe the table being referenced is Table 2. Line 336, the labels (and definitions) for FS, oFO, oFS, and FO are not in the revised figure and can be removed. Line 376 references S2_Fig when stating that “…pelvic drop of the none-involved side was not present in our TFA group…”. Please clarify how S2_Fig shows this. Lines 451-0452, suggest revising to read, “For example, the affected side ground contact in a person with TFA is different than in an unimpaired person.” Lines 454-455, the phrase “adapt the introduced”, seems incomplete. Suggest revising. Lines 455-457, suggest revising to read, “Another indicator that coronal plane gait deviations cannot purely be attributed to hip strength deficits is that a lateral trunk lean can also present in amputations below the knee.” Lines 460-461, the phrase “…the reasons behind the strength deficits and the commonly, to strength deficits attributed gait deviations…” seems incomplete. Suggest revising. Line 468, suggest revising to read, “may induce a weakening of certain muscle groups…” Line 491, suggest revising to read, “participants reported being satisfied with…” Lines 507-509 state that “Over the course of this study, an additional hypothesis was developed, i.e. that people with TFA should not have a maximum hip moment below a certain threshold to avoid gait deviations.”. There does not appear to be any indication of a threshold effect in the results. Please clarify how the current data/analyses directly test this hypothesis. Lines 515-518, suggest revising to read, “However, during walking compensation mechanisms may also be induced, e.g. by the socket, prosthetic leg length or prosthetic component related, that contribute to the net functional deficit.” Other minor comments and suggested edits (insertions/deletions in brackets), Line 80, “…reduced bone density and also [] volume loss…” Line 97, “Larger amounts of fat embedded in the residual limb[] muscles…” Line 174, “…aids differ[red] considerably from…” Line 290, “For temporal spatial parameters[,] individuals…” Line 294, “For CGA kinematic results[,] participants with…” Line 339, “…extension, and flexion) in [] both…” Line 340, “For hip abduction and adduction[,] MIMs in individuals…” Line 372-373, “However, the patter[n] described by…” Line 376, “…pelvic drop of the non[]-involved side…” Line 378, “…described a different patter[n] in a different pathology…” Line 381, “…with TFA show[,] in contrast to Trendelenburg[,] a coronal plane…” Line 389, “Although not clearly detailed[,] this muscle…” Line 415, “…individuals with TFA)[,] we observed…” Line 443, “…it may be advisable to [guarantee] passive Line 480, “…has negative impact on[] the preferred…” Line 481, “Consequentially, there seem[s] to be…” Reviewer #2: First off, I would like to thank the authors for taking time to improve their manuscript. This has really shown through in the introduction which has a better flow than in the previous version. My comments are mostly dedicated to updating the phrasing throughout the manuscript and restructuring of the discussion to make the manuscript more concise and link similar ideas together. Minor: Abstract: Line 37: please update “convenience” to “convenient” Line 45: please update “abduction, adduction[,] extension[,] and flexion” with the commas suggested Line 56: consider updating “with significantly higher ranges of motion on the involved side” to “with significantly higher ranges of motion during involved side stance phase”. I suggest adding “stance phase” to the sentence as the trunk is not a part of the involved side. Introduction: Line 81: Delete “, as described by Probsting et al.” as this is implicit with the citation. Line 87: Change “conversely” to “furthermore” as the authors are adding to the argument established in the previous sentence. Lines 97-99: Consider deleting the last sentence of this paragraph as it distracts from the points that the author has established about muscle strength and atrophy. Lines 107-112: Consider updating: “In contrast to this, a more rigid fixation of the residual limb with the prosthesis, i.e. by osseointegration, or bone anchored prostheses, in individuals with TFA may have a positive effect on muscle strength. This hypothesis was supported in a study by Leijendekkers et al. who measured muscle volume. In the monitored subject with TFA the hip abductor muscle volume increased in the sound limb by 5.5% and in the residual limb by 7.4% during 12 months after implanting the bone-anchored prosthesis [16].” to: “In contrast to this, a more rigid fixation of the residual limb with the prosthesis, i.e. by osseointegration, or bone anchored prostheses, in individuals with TFA can have a positive effect on muscle strength [16].” Methods: The methods overall read nicely. Page 11: Thank you for including more information regarding you TFA population and the procedure for prosthetic/socket fit. Line 219: Consider deleting “following Kadaba et al. and Davis et al.” as this information is included in the citations. Line 224: “was” to “were” Line 230: consider adding the following commas to the sentence: “The OpTIMo device[,] used to determine isometric hip moment[s][,] consist of a rigid frame….” Lines 278-279: consider deleting “as well” as it makes the sentence clunky Results: The results read nicely. Line 290: add a comma between “parameters” and “individuals” Line 294: add a comma between “results” and “participants” Discussion: The following are recommendation to make the discussion more concise and to bring together similar ideas that were throughout the discussion. Line 356: consider deleting “TTA” and updating the sentence to “persons with TFA” because it does not make sense to connect the results with persons with TTA as they are a completely different population. Lines 357-361: consider deleting these two sentences as it has you have already summarized these results in the previous sentence. Line 362-363: Why do the authors think that there was no strength deficit in hip extension as there were deficits the other directions? The authors have an explanation for this later in the discussion. I would recommend that they move lines 472-482 to the end of this paragraph. Please update some of these sentences as to not use the [author] et al…. (explanation). Updating the sentence structure will make the sentences clear and concise. Line 367: consider updating “range” to “range-of-motion” Lines 371-378: Consider deleting these sentences as they do not add meaningful content to the author’s discussion as these sentences are dedicated to a population with a different pathology – which is stated in the last sentence fragment. Line 369: Consider adding the following to the end of the sentence: “, as has been observed in people with TFA [24,25,42,45]”. The authors can then delete the sentence from lines 379-380. Lines 383-391: It is suggested not to use the phrasing: [author] et al. showed….. this style of writing makes these sentences difficult to read. This information may be able to be summarized concisely. For example: “Altered trunk and hip kinematics exhibited in persons with TFA have been attributed to weak hip musculature [13,24,42].” The authors could then move lines 398-403 after this statement as it connects very well. In my opinion, the authors should have the caveat in this paragraph that such a correlation was not observed in the healthy population. The S2 Figure (which I like) shows that less strength in the REF group would have a reduced trunk obliquity (p=0.02). For instance: (the following is a suggestion for the authors, linking these statements together eliminates the reader having to go back and forth between paragraphs separated by another paragraph) Altered trunk and hip kinematics exhibited in persons with TFA have been attributed to weak hip musculature [13,24,42]. This connection may explain the observed, non-significant, moderate negative correlation between hip abduction MIM and trunk obliquity range-of-motion. This correlation indicates that weaker people with TFA have the tendency to show a greater trunk range-of-motion during walking than their stronger piers. However, it should be noted that this is the exact opposite trend that was observed in the healthy population (S2 Fig.). This may lead to lines 403-406 may be able to be appended (with some editing) to the paragraph from lines 392-397. Lines 409-410: consider update the start of the sentence to: “In typically developing children, the hip MIM…” Line 426: consider updating “contradictable” to “difficult” Lines 441-443: This sentence is very similar to the previous. It is recommended to end the sentence on line 441 with two citations [44,45] to eliminate the redundancy. I recommend then moving lines 445-447 after this sentence because it directly connects. For example: “For example, it is well accepted that quadrilateral sockets do not stabilize the femur in the coronal plane and therefore will more likely cause increased residual limb movement during walking, compared to other designs, e.g. ischial containment sockets [44, 45]. Decreased medio-lateral stability residuum and the femur, as a cause for a lateral trunk motion, along with other cofounding factors, like strength deficits of the hip abductors the socket [46]. The strength status of people with TFA is therefore of high clinical relevance.” This recommendation does remove “So, in socket design it may be advisable to grantee passive stability and a very good force transmission, while not restricting the remaining muscles.” however, the proposed change does capture the importance of socket design. 499: “K_level” to “K-level” Conclusion: Looks good! Reviewer #3: The authors made significant improvements to the manuscript. Overall, the writing is better and the authors have addressed my and other reviewer's comments. There a few minor issues to revise before being ready for publication. Slight formatting issues with table 1, column width is too narrow. Line 28: I am assuming you mean mass, not weight. Line 443: grantee, incorrect word? Repeated use of consequentially, a different word or phrase in few instances to improve readability Check for consistent spacing after periods, fluctuates between 0 to 2 spaces Check - versus _ in regards to K-levels (e.g., lines 498-499) Thank you for addressing our comments. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Scott A. Beardsley Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
PONE-D-19-24706R2 The influence of hip muscle strength on gait in individuals with a unilateral transfemoral amputation PLOS ONE Dear Dr. Heitzmann, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Sep 11 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Yih-Kuen Jan, PhD Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: I would like to commend the authors on re-writing their manuscript. This manuscript represents a significant knowledge contribution in terms of how strength deficits can affect walking performance for persons with transfemoral amputation. Below I have listed some minor comments regarding word choice and punctuation. Line 67: “later” to “lateral” Line 89: comma between “imaging” and “involved” Line 90-91: suggest to update the sentence to: “This led to altered walking biomechanics and residual limb muscle activation patterns after a TTA [6]” Line 118: “Beside” to “Besides” Line 137: comma between “secondly” and “we” Line 139: Replace semicolon with period and comma between “Finally” and “we” line 147: comma between “data” and “maximum” line 192: comma between “documentation” and “none” line 220: consider updating the start of this sentence to: “As shown by Pamies-Vila et al., changes of the…” line 242: comma between “measurements” and “a” Discussion: The flow of the discussion has improved greatly! Thank you for taking time and updating this section. Line 378: “will” to “would” Line 378: comma between “gait” and “this” line 386 “lead” to “led” line 392: “conclude” to “concluded” line 403: “transition” to “transmission” Line 403-404: recommend updating the wording of this sentence to: “A reduced power transmission between the stump and the socket may cause the observed muscle weakness to manifest a more pronounced functional deficit.” Line 406: “transition” to “transmission” Line 412: comma between “discrepancy” and “was” Reviewer #3: The authors addressed reviewers comments during this second review, so thank for continued improvements on this manuscript. Readability and clarity have been improved. There are a few more minor changes to be made: Abstract: Line 64: "i.e. later[al] trunk" Line 68: "between later[al]" Introduction: Line 92: "ultrasound imaging[,] involved" Line 149: "movement; [f]inally we" Methods: Looks good, no suggested changes. Results: Looks good, no suggested changes. Discussion: Line 357: "First and foremost" is colloquial, could say "Our data shows that..." Line 443: "it was conclud[ed]..." Line 464: Remove 'A' at start of "A decreased..." Line 465: Remove comma after "factors" Line 466: Add comma after "discrepancy" Conclusion: Looks good, no suggested changes. Thank you again for your continued work on this manuscript! ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Scott A. Beardsley Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 3 |
|
The influence of hip muscle strength on gait in individuals with a unilateral transfemoral amputation PONE-D-19-24706R3 Dear Dr. Heitzmann, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Yih-Kuen Jan, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: I would like to thank the authors once again for their continued work through this review process. The authors have a well written and scientifically sound manuscript. I have included a few minor suggestions. I feel that this manuscript is ready for publication. Make sure that there is consistent punctuation after e.g. and i.e. Sometimes the authors include a comma after these abbreviations and sometimes not. Line 220: comma after “al.” Line 221: “effects” to “effect”, “in” to “on” Line 371: remove “was” Line 404: there is an extra period Reviewer #3: The authors have made the necessary changes to the manuscript and now have an article that is ready for publication. Thank you for your efforts! ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Scott A. Beardsley Reviewer #2: No Reviewer #3: No |
| Formally Accepted |
|
PONE-D-19-24706R3 The influence of hip muscle strength on gait in individuals with a unilateral transfemoral amputation Dear Dr. Heitzmann: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Yih-Kuen Jan Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .